Sort
30,917 grants matching “tumor microenvironment”
Translation of a novel combination therapy approach for non-Hodgkin lymphoma
$625,851Shruthi Naik · Mayo Clinic Rochester · U01 · FY2023 · CA
TRPV1 nociceptors in oral carcinogenesis and pain
$625,751Donna G Albertson · New York University · R01 · FY2021 · CA
Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer
$625,751Amir Zarrinpar · University Of California, San Diego · U01 · FY2025 · CA
Neuronal Regulation of Low-Grade Gliomagenesis
$625,706Michelle Monje-Deisseroth · Stanford University · R01 · FY2023 · CA
The linkage between Race, Kaiso and the tumor microenvironment in breast cancer health disparities
$625,704Kevin L. Gardner · Columbia University Health Sciences · R01 · FY2024 · CA
Identifying senescence and immune biomarkers predictive of benefit to combined CDK4 and checkpoint blockade inhibition in patients with dedifferentiated liposarcoma
$625,681Sandra P D'angelo · Sloan-Kettering Inst Can Research · R01 · FY2025 · FD
Decoding tobacco-related oral cancer ecosystem by integrative approach
$625,660Aik Choon Tan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · DE
High Content Representation and Association of 3D Cell Culture Models
$625,635Bahram A. Parvin · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2012 · CA
An automated high-throughput tissue model for screening metastatic effectors
$625,580David J Beebe · University Of Wisconsin-Madison · R01 · FY2018 · CA
An automated high-throughput tissue model for screening metastatic effectors
$625,580David J Beebe · University Of Wisconsin-Madison · R01 · FY2016 · CA
An automated high-throughput tissue model for screening metastatic effectors
$625,580David J Beebe · University Of Wisconsin-Madison · R01 · FY2017 · CA
Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma
$625,527David Charles Lyden · Weill Medical Coll Of Cornell Univ · U01 · FY2012 · CA
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE
$625,517Kooresh Isaac Shoghi · Washington University · U24 · FY2020 · CA
Dissecting Phenotype Switching in Early Stage Melanomas
$625,456Markus Schober · New York University School Of Medicine · R01 · FY2025 · CA
Naive T cells in Cancer Immune Evasion and Immunotherapy
$625,446Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Type 2 immunity: a primitive response to epithelial injury that shapes bone marrow and lung myeloid crosstalk
$625,412Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME)
$625,319Xueding Wang · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Non-canonical Wnt-Receptor Signaling and Targeted Therapies
$625,253Thomas J. Kipps · University Of California, San Diego · R01 · FY2023 · CA
The Impact of FUS-Mediated Brain Cancer Therapy on BBB Transport, Cytokines, and Immunocyte Trafficking
$625,207Kim Butts Pauly · Stanford University · R01 · FY2020 · CA
Targeting Neoantigens in Triple Negative Breast Cancer
$625,110William E Gillanders · Washington University · R01 · FY2023 · CA
Targeting Neoantigens in Triple Negative Breast Cancer
$625,095William E Gillanders · Washington University · R01 · FY2022 · CA
Non-canonical Wnt-Receptor Signaling and Targeted Therapies
$625,082Thomas J. Kipps · University Of California, San Diego · R01 · FY2022 · CA
Mechanisms of impaired T-cell mechanosensing of melanoma antigens
$625,074Cheng Zhu · Georgia Institute Of Technology · U01 · FY2019 · CA
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer
$625,024Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
$624,971Gerald V Denis · Boston University Medical Campus · R01 · FY2019 · CA